Merus
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Merus and other ETFs, options, and stocks.About MRUS
Merus NV is a clinical-stage immuno-oncology company, which engages in the discovery and development of bispecific antibody therapeutics. Its pipeline includes Biclonics for solid and hematological tumors.
MRUS Key Statistics
Stock Snapshot
With a market cap of 7.22B, Merus(MRUS) trades at $95.17. The stock has a price-to-earnings ratio of -17.84.
During the trading session on 2025-11-07, Merus(MRUS) shares reached a daily high of $95.26 and a low of $95.07. At a current price of $95.17, the stock is +0.1% higher than the low and still -0.1% under the high.
Trading volume for Merus(MRUS) stock has reached 342.96K, versus its average volume of 1.15M.
Over the past 52 weeks, Merus(MRUS) stock has traded between a high of $95.35 and a low of $33.19.
Over the past 52 weeks, Merus(MRUS) stock has traded between a high of $95.35 and a low of $33.19.
MRUS News
William Blair analyst Matt Phipps has maintained their neutral stance on MRUS stock, giving a Hold rating on October 24. Elevate Your Investing Strategy: Take a...
Merus NV (MRUS) has disclosed a new risk, in the Innovation / R&D category. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Un...